The firm maintained its $42 price target on the Cincinnati-based grocery retail chain, citing positive long-term prospects and its strong multi-local position, TheFly reports.
Kroger also utilizes technology that's far more advanced than its competitors to push sales promotions, on-trend merchandising and in-store experience, according to TheFly.
Last month, Kroger announced it had reached an agreement with Axium Pharmacy to buy outstanding shares of ModernHEALTH and form a new combined specialty pharmacy. The company said it hopes the deal will give their customers access to a more diverse range of medications.
Separately, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author. TheStreet Ratings has this to say about the recommendation:
We rate KROGER CO as a Buy with a ratings score of A-. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, good cash flow from operations and notable return on equity. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.
You can view the full analysis from the report here: KR